APA Zitierstil

Zhang, Y., Xie, C., Li, A., Liu, X., Xing, Y., Shen, J., . . . Ma, D. (2019). PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway. Am J Transl Res.

Chicago Zitierstil

Zhang, Yinci, et al. "PKI-587 Enhances Chemosensitivity of Oxaliplatin in Hepatocellular Carcinoma Through Suppressing DNA Damage Repair Pathway (NHEJ and HR) and PI3K/AKT/mTOR Pathway." Am J Transl Res 2019.

MLA Zitierstil

Zhang, Yinci, et al. "PKI-587 Enhances Chemosensitivity of Oxaliplatin in Hepatocellular Carcinoma Through Suppressing DNA Damage Repair Pathway (NHEJ and HR) and PI3K/AKT/mTOR Pathway." Am J Transl Res 2019.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.